Dallas Leigh Upchurch, | |
345 Owen Ln Ste 144a, Waco, TX 76710-5587 | |
(254) 300-4072 | |
(254) 362-2064 |
Full Name | Dallas Leigh Upchurch |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Location | 345 Owen Ln Ste 144a, Waco, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013551233 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363L00000X | Nurse Practitioner | 1073418 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dallas Leigh Upchurch, 821 Kendra Dr, Temple, TX 76502-5878 Ph: (706) 326-6088 | Dallas Leigh Upchurch, 345 Owen Ln Ste 144a, Waco, TX 76710-5587 Ph: (254) 300-4072 |
News Archive
Masimo Corporation announced today that its Pronto-7 handheld noninvasive hemoglobin, arterial oxygen saturation (SpO2), pulse rate, and perfusion index spot-check testing device has received the GOLD 2011 Medical Design Excellence Award—the highest award given in the general hospital devices and therapeutic products category.
Capping SUNY Downstate Medical Center's growth into a major center for eye research, Research to Prevent Blindness (RPB) has awarded SUNY Downstate a four-year challenge grant of $220,000 to spur the development of advanced research into the causes, treatment, and prevention of blinding diseases. Douglas R. Lazzaro, MD, professor and chair of ophthalmology, is the principal investigator.
Presidio Networked Solutions, Inc., the leading provider of professional and managed services for the full lifecycle of advanced IT infrastructure solutions, today announced it will host an exclusive Healthcare Technology Executive Summit on October 15, in partnership with Cisco Systems, Radianta and Ekahau.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today signed a Business Cooperation Agreement with South Korea-based Celltrion, Inc. and Celltrion Healthcare, Inc. ("Celltrion"), which outlines the business terms of a future distribution agreement for the United States, Europe, Australia, New Zealand and Canada for eight biogeneric products that are currently under development by Celltrion, five of which are incremental to Hospira's pipeline.
Adamis Pharmaceuticals Corporation announced today that in addition to its activity in prostate cancer, its drug APC-300 significantly inhibits the growth of pancreatic cancer cells.
› Verified 9 days ago
Leslie P Smith, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1800 Gurley Lane, Waco, TX 76706 Phone: 254-313-6000 Fax: 254-313-4531 | |
Eidel Nerli Adams, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6901 Medical Pkwy, Waco, TX 76712 Phone: 254-751-4000 | |
Karen Church, APRN, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 611 W Hwy 6 Ste 101, Waco, TX 76710 Phone: 254-755-4582 | |
Emily Heeringa, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 | |
Jared Blake Griffin, NNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2900 | |
Andrea Denise Nemec, NNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-5300 |